Literature DB >> 2878670

Neural basis of psychomotor stimulant and opiate reward: evidence suggesting the involvement of a common dopaminergic system.

M A Bozarth.   

Abstract

Data are reviewed that suggest a common neural system may be involved in the rewarding properties of psychomotor stimulant and opiate drugs. This neural system corresponds to elements in the ventral tegmental dopamine system with cell bodies in the ventral tegmentum and axon terminals in the nucleus accumbens. Several lines of evidence have shown that psychomotor stimulant reward involves a drug action in the nucleus accumbens and that opiate reward involves a drug action in the ventral tegmentum. Activation of the ventral tegmental system at either synaptic element can produce reinforcement by an enhancement of dopaminergic neurotransmission in the nucleus accumbens. Although additional brain systems may be involved in the rewarding actions of these compounds, their ability to activate the ventral tegmental dopamine system appears to make an important contribution to their net reinforcing impact.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2878670     DOI: 10.1016/0166-4328(86)90032-x

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  12 in total

Review 1.  Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine.

Authors:  E L Ochoa; L Li; M G McNamee
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

3.  Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine.

Authors:  B T Lett
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Apomorphine effects on emotional modulation of the startle reflex in rats.

Authors:  Mathew T Martin-Iverson; Kirsten N Stevenson
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

5.  An in vivo microdialysis assessment of concurrent MDMA and cocaine administration in Sprague-Dawley rats.

Authors:  John J Panos; Lisa E Baker
Journal:  Psychopharmacology (Berl)       Date:  2010-01-30       Impact factor: 4.530

6.  Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.

Authors:  F Noble; B M Cox
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

Review 7.  Nicotine-related brain disorders: the neurobiological basis of nicotine dependence.

Authors:  E L Ochoa
Journal:  Cell Mol Neurobiol       Date:  1994-06       Impact factor: 5.046

8.  Naltrexone blocks amphetamine-induced hyperactivity, but not disruption of social and agonistic behavior in mice and squirrel monkeys.

Authors:  J T Winslow; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

9.  Dopamine and sexual behavior in the male rat: a reevaluation.

Authors:  A Agmo; H Fernández
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

10.  Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.

Authors:  L Ugedo; J Grenhoff; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.